Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice

Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy.
of 7
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
  113 Journal of Neuropathology and Experimental Neurology  Vol. 63, No. 2Copyright    2004 by the American Association of Neuropathologists February, 2004pp. 113 119 Activated p38MAPK Is a Novel Component of the Intracellular Inclusions Found in HumanAmyotrophic Lateral Sclerosis and Mutant SOD1 Transgenic Mice C ATERINA  B ENDOTTI , P H D, C RISTIANA  A TZORI , P H D, R OBERTO  P IVA , P H D, M ASSIMO  T ORTAROLO , P H D,M ICHAEL  J. S TRONG , MD, S ILVIA  D E B IASI , P H D,  AND  A NTONIO  M IGHELI , MD, P H D Abstract.  Cytoskeletal abnormalities with accumulation of ubiquilated inclusions in the anterior horn cells are a pathologicalhallmark of both familial and sporadic amyotrophic lateral sclerosis (ALS) and of mouse models for ALS. Phosphorylatedneurofilaments besides ubiquitin and dorfin have been identified as one of the major components of the abnormal intracellularperikaryal aggregates. As we recently found that p38 mitogen-activated protein kinase (p38MAPK) colocalized with phos-phorylated neurofilaments in spinal motor neurons of SOD1 mutant mice, a model of familial ALS, we investigated whetherthis kinase also contributed to the inclusions found in ALS patients and SOD1 mutant mice. Intense immunoreactivity foractivated p38MAPK was observed in degenerating motor neurons and reactive astrocytes in ALS cases. The intracellularimmunostaining for activated p38MAPK appeared in some neurons as filamentous skein-like and ball-like inclusions, withan immunohistochemical pattern identical to that of ubiquitin. Intracellular p38MAPK-positive aggregates containing ubiquitinand neurofilaments were also found in the spinal motor neurons of SOD1 mutant mice. Our observations indicate thatactivation of p38MAPK might contribute significantly to the pathology of motor neurons in ALS. Key Words:  Amyotrophic lateral sclerosis; Inclusion; MAP kinase; p38MAPK; SOD1; Ubiquitin. INTRODUCTION Amyotrophic lateral sclerosis (ALS) is a late-onset neu-rodegenerative disease characterized by selective degener-ation and death of motor neurons in spinal cord, brainstem,and cerebral cortex. About 10% of ALS cases are familial,with one fifth linked to various dominantly inherited mu-tations of the gene encoding the copper-zinc superoxide dis-mutase (SOD1) (1, 2). The clinical and pathological ex-pression of ALS is similar between familial and sporadicforms. A hallmark of all types of ALS is the cytoplasmicaccumulation of ubiquitylated skein-like inclusions in motorneurons of the spinal cord (3–5). Lewy body-like inclu-sions, although not typical for ALS, are also found. Besidesphosphorylated neurofilaments and ubiquitin, the latter in-clusions contain Cdk5 kinase (6, 7). Neurofilamentproteins,together with peripherin and kinesin, are also detected inthe majority of spheroids, i.e. the axonal swellings of motorneurons (8–10). More recently, dorfin, a RING finger-typeE3 ubiquitin ligase, has also been localized in the inclusionbodies found in the motor neurons and neuronal processesof familial and sporadic ALS (11, 12) Altogether, theseinclusions are likely to be responsible for the dysfunctionand progressive degeneration of motor neurons (13). Data From Department of Neuroscience (CB, MT), Istituto di RicercheFarmacologiche Mario Negri, Milan, Italy; Rita Levi Montalcini Centerfor Brain Repair, Department of Neuroscience (CA, RP, AM), Univer-sity of Turin, Italy; Cell Biology Research Group (MJS), Robarts Re-search Institute, London, Ontario, Canada; Department of BiomolecularSciences and Biotechnologies (SD), University of Milan, Milan, Italy.Correspondence to: Dr. Caterina Bendotti, Laboratory of MolecularNeurobiology, Dept. Neuroscience, Istituto di Ricerche FarmacologicheMario Negri, Via Eritrea, 62, 20157, Milano, Italy. E-mail: bendotti@marionegri.itThe financial support of Telethon, Italy (GP0222Y01), fondazioneMonzino and MND Association, UK is greatly acknowledged. from various in vitro and in vivo models suggest that phos-phorylation of neurofilaments is critical in their aggregationprocess; however, the kinase(s) involved remain to be iden-tified.The pathology of ALS, including formation of the ab-normal intracellular inclusions, is strikingly mimicked byseveral lines of transgenic mice overexpressing the humanALS-linked SOD1 gene mutations (14, 15). Several hy-potheses have been proposed to explain the selective motorneuron toxicity linked to mutant SOD1, including elevatedoxidative stress, glutamate excitotoxicity and cytoskeletalabnormalities (13, 16). Recently, we found a remarkableactivation of p38 mitogen-activated protein kinase(p38MAPK) in the spinal cord of transgenic mice carryingthe human G93A SOD1 gene mutation (TgSOD1G93A),during the progression of disease (17). p38MAPK is animportant mediator of signal transduction in response to avariety of extracellular stimuli and is implicated in diversefunctions, including phosphorylation of cytoskeletal pro-teins (18, 19). Interestingly, in motor neurons of Tg-SOD1G93A mice at the initial phase of disease, we ob-served increased labeling of p38MAPK that colocalizedwith phosphorylated neurofilaments in degenerating peri-karya and neurites, suggesting a role of this kinase in neu-rofilament phosphorylation (17). In this report we used im-munohistochemical tools to investigate the localization of activated p38MAPK in the intracellular inclusions of spo-radic human ALS and SOD1 mutant mice. MATERIALS AND METHODSHuman Tissues Spinal cords from sporadic ALS (n    5, mean age at death59 years) and control patients affected by non-neurological dis-eases (n    5, mean age at death 66 years) were used (Table).  114  BENDOTTI ET AL  J Neuropathol Exp Neurol, Vol 63, February, 2004 TABLEClinical Data of Human Cases Selected for the StudyCase DiseaseAge atdeathDuration(months)PMI(hours)12345678sALSsALSsALSsALSsALSsALSsALSsALS53645660655069602136442518601014121181513121210910111213141516sALSNCNCNCNCNCNCParkinson527556687071556448——————No motor pathology1218152012161317Abbreviations: sALS    sporadic amyotrophic lateral sclero-sis; NC    normal control; PMI    postmortem interval. → Fig. 1. A:  Normal human spinal cord ( a ). Only weak p38MAPK immunoreactivity is present in motor neurons. ALS spinalcord ( b–d ). Low magnification of anterior horn showing strong p38MAPK immunoreactivity ( b ). p38MAPK is found in bothnucleus and cytoplasm of reactive astrocytes ( c ). p38MAPK is present in the cytoplasm of an atrophic motor neuron and withinits swollen axon ( d,  arrow). Magnifications: a, b,   400; c, d,   1,000.  B:  Examples of skein-like p38MAPK-positive inclusionsin ALS motor neurons. In ( a ), the filamentous inclusions are located in the peripheral region of the perikaryon and inside theproximal neurite (arrow). A highly immunoreactive small cell, presumably a glial cell, is also observed (arrowhead). Other skein-like inclusions ( b, c ) are disordered in atrophic motor neurons around the nucleus. In ( d ), the aggregates appear as tangled skeinsfilling the entire cell. Magnification:   1,000.  C:  Comparative immunostaining of ubiquitin ( a ) and p38MAPK ( b ) in ALS motorneurons. Note the striking similarity in the morphology of the skein-like inclusions. Magnification:   1,000.Duration of illness in ALS cases ranged between 10 and 60months. All cases had been autopsied within 8 to 15 hours fromdeath. Tissues were fixed in formalin and embedded in paraffin. Mouse Tissues Female C57BL/6 and transgenic mice were maintained at atemperature of 21    1  C with relative humidity 55%    10%and 12 hours of light. Food (standard pellets) and water weresupplied ad libitum. Transgenic mice srcinally obtained fromJackson Laboratories (Bar Harbor, ME) and expressing highcopy number of mutant human SOD1 with a Gly 93 Ala sub-stitution (TgSOD1G93A) were bred and maintained on aC57BL/6 mice strain at the Consorzio Mario Negri Sud (S.Maria Imbaro, Italy). Transgenic mice were identified by poly-merase chain reaction (PCR) (1). These mice become symptom-atic at around 11 weeks and die at about 21 to 22 weeks of age. A 52%    5% (SE) motor neuron loss is found in the oldestmice compared to age-matched controls (20). Female mice werekilled at 10 and 14 weeks of age corresponding respectively toa presymptomatic and early symptomatic stage of the progres-sion of the motor dysfunction. Tg SOD1 G93A (n    18) andnon-transgenic (n    6) mice combined in age groups of 9, 14,and 19 weeks were fixed by perfusion with 4% paraformalde-hyde and their spinal cords embedded in paraffin for light mi-croscopy or in hydrophilic resin (LR white acrylic resin, Sigma,Poole, UK) for electron microscopy.Procedures involving animals and their care were conductedin conformity with the institutional guidelines that are in com-pliance with national and international laws and policies and allefforts were made to minimize the number of animals used andtheir suffering. Immunocytochemistry All light microscopic analyses were performed on 5-  m sec-tions from cervical and lumbar spinal cord. To detectp38MAPK, we used a polyclonal antibody that selectively rec-ognizes its activated (phosphorylated) form (1/100 dilution,New England Biolabs, Beverly, MA or 1/500 dilution, Calbi-ochem, Nottingham, UK). Other primary antibodies used in thestudy were a polyclonal anti-phosphorylated JNK (1/100, NewEngland Biolabs), a monoclonal anti-ubiquitin (1/5000, Chem-icon International, Harrow, UK), a mouse monoclonal anti-phosphorylated neurofilaments (SMI 31, 1/5000, Sternberger,Lutherville, MD). In some cases, sections were treated withtrypsin before immunostaining. Specificity of p38MAPK im-munoreactivity was tested by preadsorbing the primary anti-body with the immunizing peptide (kindly provided by Dr. A.Nelsbach, New England Biolabs). Complete abolishment of thestaining was achieved using 0.5   g/ml of the antibody and 50  g/ml of the peptide. Immune reactions were revealed bystreptABC using either DAB or AEC as peroxidase substrate.Sections were counterstained with hematoxylin. For double la-beling studies, serial sections were used or, alternatively, sec-tions were first immunostained for p38MAPK with AEC as sub-strate and photographed. After ethanol decoloration and elutionof anti- p38MAPK antibody with HCl, sections were immu-nostained with another primary antibody using DAB as sub-strate. For electron microscopy, thin sections of the ventral hornwere collected on Formvar-coated nickel grids and processedwith a standard post-embedding immunogold staining protocol.Briefly, the grids were incubated overnight in either 1) a poly-clonal anti-phosphorylated p38MAPK antiserum (1/250, Cal-biochem, Nottingham, UK), 2) a monoclonal anti-ubiquitin an-tiserum (1/1000, Chemicon International, Harrow, UK), or 3) amixture of the 2 primary antisera. After being thoroughly rinsedin buffers, the grids were incubated for 1 hour at room tem-perature in a goat-anti rabbit secondary antiserum conjugatedto 15 nm gold particles (British Biocell International, Cardiff,UK) (to detect p38MAPK) or in a goat-anti mouse secondary  115 p38 LABELED INCLUSIONS IN ALS  J Neuropathol Exp Neurol, Vol 63, February, 2004  116  BENDOTTI ET AL  J Neuropathol Exp Neurol, Vol 63, February, 2004 Fig. 2. A:  p38MAPK immunoreactivity in TgSOD1G93A mice. Examples of p38MAPK in motor neurons with normallooking appearance ( a ), or with severe ( c ) vacuolar changes ( b ). Reactive astrocytes at the border of large vacuoles are alsostrongly p38MAPK-positive ( c ). Magnification:   1,000.  B:  Examples p38MAPK-positive inclusions in the ventral horn of TgSOD1G93A mice. Large p38MAPK-positive inclusions are found in the ventral horn ( a ) and in the ventral tracts ( b ). Doublelabeling for p38MAPK ( c ) and ubiquitin ( d ) in the same inclusion. A swollen p38MAPK-positive neurite ( e,  arrow) is also labeledfor phosphorylated neurofilaments ( f  ). Magnification:   1,000.antiserum conjugated to 15 nm gold particles (to detect ubiq-uitin), whereas for double labeling the grids were first incubatedin a biotinylated goat-anti rabbit secondary antiserum and thenin a mixture of streptavidin conjugated to 5 nm gold particles(to detect p38MAPK) and of a goat-anti mouse secondary an-tiserum conjugated to 15 nm gold particles (to detect ubiquitin).Control grids were processed in the same way, with omissionof the primary antiserum. All grids were counterstained withaqueous uranyl acetate and lead citrate and then observed andphotographed with a Jeol T8 electron microscope. RESULTS Some of the present series of ALS cases had been pre-viously analyzed for the expression of the JNK family of MAPKs and of the transcription factor NF  B (21). Toexamine if p38MAPK had the same expression patternof JNK, serial sections of spinal cord were consecutivelyimmunostained for the 2 MAPKs. In control tissues, im-munoreactivity for p38MAPK reflected that of JNK,showing light cytoplasmic staining in motor neurons (Fig.1Aa). Striking upregulation of p38MAPK occurred inALS spinal cord (Fig. 1Ab). Similar to JNK, p38MAPKwas abundantly expressed by reactive astrocytes in theanterior horns and pyramidal tracts, i.e. the areas char-acterized by prominent gliosis in ALS (Fig. 1Ac). At var-iance with JNK, however, strong p38MAPK immunore-activity was also found in the majority of motor neurons,with the highest staining intensity in atrophic and degen-erating neurons.As shown in Figure 1B, some motor neurons showeda perikaryal distribution of p38MAPK immunoreactivitythat appeared as filamentous aggregates of various com-plexities. In some cases, the labeled filamentous inclu-sions were organized in a circular pattern around the nu-cleus, or in arrays located in the peripheral region of theneuron and in neurites. A comparison between ubiquitinand p38MAPK immune reactivity showed a striking sim-ilarity in the morphology of the labeled inclusions (Fig.1C).As we have previously shown (17), p38MAPK wasconstitutively activated in the substantia gelatinosa of dorsal horns in both wild type and Tg SOD1 G93A mice,while weak staining for p38MAPK was found in motorneurons of control mice. On the contrary, Tg SOD1G93A mice showed a striking activation of p38MAPK in  117 p38 LABELED INCLUSIONS IN ALS  J Neuropathol Exp Neurol, Vol 63, February, 2004 Fig. 3.  Ultrastructural immunogold localization of p38MAPK and ubiquitin in filamentous intracellular aggregates in theventral horn of TgSOD1G93A mice.  A:  Single labeling for p38MAPK (revealed by 15 nm gold particles).  B:  Single labeling forubiquitin (revealed by 15 nm gold particles).  C:  Colocalization of p38MAPK (revealed by 5 nm gold particles, some indicatedby arrows) and ubiquitin (revealed by 15 nm gold particles) in the same aggregate. Magnification:  A ,  B ,   64,000;  C ,   120,000. motor neurons (Fig. 2A) that was more pronounced indegenerating ones. Vacuolated motor neurons showedprominent activation of p38MAPK that persisted even inend stages of destruction (Fig. 2Ab). Reactive glial cellslocated at the border of large vacuoles were also stronglyp38MAPK-immunoreactive (Fig. 2Ac).More advanced stages in Tg SOD1 G93A mice arecharacterized by progressive accumulation of cytoplasmicinclusions. Analysis of sections revealed a large numberof p38MAPK-positive inclusions in the ventral horns(Fig. 2Ba) and less frequently in the intraspinal portionof the ventral roots (Fig. 2Bb).To evaluate p38MAPK colocalization with other mol-ecules found in the aggregates, we performed double la-beling studies using antibodies to p38MAPK, ubiquitin,and phosphorylated neurofilaments. The analysis re-vealed that p38MAPK-positive inclusions also containedubiquitin (Fig. 2B, c–d) and phosphorylated neurofila-ments (Fig. 2B, e–f).To confirm the light microscopic data, we performedan ultrastructural investigation on the ventral horn of TgSOD1 G93A mice. Selective deposition of gold particles,indicating p38MAPK immunolabeling, was found on cy-toplasmic aggregates consisting of irregularly oriented fil-aments (Fig. 3A). In adjacent sections, similar filamen-tous aggregates appeared labeled by the anti-ubiquitinantiserum (Fig. 3B). Double labeling on the same thinsection revealed that p38MAPK-positive aggregates alsocontained ubiquitin (Fig. 3C). Immunogold labeling wasabsent in sections from non-transgenic and control mice(not shown). DISCUSSION This study shows that activated p38MAPK accumu-lates in the cytoplasm of degenerating motor neurons andastrocytes in both human ALS and transgenicSOD1G93A mice. The most striking observation is thepresence of activated p38MAPK in the intracellularskein-like inclusions of human ALS. These are hetero-geneous inclusions with an overall filamentous appear-ance that so far have been only detected with antibodiesto ubiquitin and dorfin (4, 6, 11, 12, 22). Using immu-noelectron microscopy techniques, phosphorylated neu-rofilament epitopes were found at the periphery of theskeins, suggesting that neurofilaments are a componentof the inclusions (23). Phosphorylated neurofilaments arenormally distributed along the axon or in the axon ter-minals. When they become phosphorylated their trans-port is impaired, leading to accumulation in the perikaryaor in the proximal axon (24, 25). Indeed, direct measure-ments of axonal transport in several transgenic mousemodels of ALS have revealed that slowing of neurofila-ment transport is a common and early pathological fea-ture (26, 27). Among the various kinases that are able tophosphorylate neurofilaments in vitro, members of theMAPK family play a relevant role (24). Recently, we
Similar documents
View more...
Related Search
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks